✦ LIBER ✦

Irbesartan treatment of patients with type 2 diabetes, hypertension and renal disease: a UK health economics analysis

✍ Scribed by A. J. Palmer; W. J. Valentine; J. A. Ray

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Health economic implications of irbesart

✍ Andrew J. Palmer; William J. Valentine; Joshua A. Ray; Stephane Roze; Noemi Musz 📂 Article 📅 2007 🏛 Springer 🌐 French ⚖ 212 KB

Health economics studies assessing irbes

✍ Palmer, Andrew J.; Rodby, Roger A. 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 67 KB

Irbesartan approved in Canada for renal

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

PDB24 A COST-EFFECTIVENESS ANALYSIS OF I

✍ TJ Lee; DS Han; HS Sohn 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCV32 COST-EFFECTIVENESS OF IRBESARTAN I

✍ H Hernandez; L Lepe; A Gonzalez; A Lemus 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

An Asian Regional Analysis of Cost-Effec

✍ Lieven Annemans; Nadia Demarteau; Shanlian Hu; Tae-Jin Lee; Zaher Morad; Thanom 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB